These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34594115)

  • 1. Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis.
    Pelaia C; Lombardo N; Busceti MT; Piazzetta G; Crimi C; Calabrese C; Vatrella A; Pelaia G
    J Asthma Allergy; 2021; 14():1165-1172. PubMed ID: 34594115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma.
    Laidlaw TM; Bachert C; Amin N; Desrosiers M; Hellings PW; Mullol J; Maspero JF; Gevaert P; Zhang M; Mao X; Khan AH; Kamat S; Patel N; Graham NMH; Ruddy M; Staudinger H; Mannent LP
    Ann Allergy Asthma Immunol; 2021 May; 126(5):584-592.e1. PubMed ID: 33465455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial.
    Bachert C; Mannent L; Naclerio RM; Mullol J; Ferguson BJ; Gevaert P; Hellings P; Jiao L; Wang L; Evans RR; Pirozzi G; Graham NM; Swanson B; Hamilton JD; Radin A; Gandhi NA; Stahl N; Yancopoulos GD; Sutherland ER
    JAMA; 2016 Feb; 315(5):469-79. PubMed ID: 26836729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupilumab Efficacy in Patients With Uncontrolled or Oral Corticosteroid-Dependent Allergic and Nonallergic Asthma.
    Brusselle G; Quirce S; Papi A; Kuna P; Chipps BE; Hanania NA; Blaiss M; Msihid J; Jacob-Nara JA; Deniz Y; Rowe PJ; Gall R; Ortiz B; Djandji M; Radwan A
    J Allergy Clin Immunol Pract; 2023 Mar; 11(3):873-884.e11. PubMed ID: 36572184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life.
    Nettis E; Brussino L; Patella V; Bonzano L; Detoraki A; Di Leo E; Sirufo MM; Caruso C; Lodi Rizzini F; Conte M; Yacoub MR; Triggiani M; Ridolo E; Macchia L; Rolla G; Brancaccio R; De Paulis A; Spadaro G; Di Bona D; D'Uggento AM; Ginaldi L; Gaeta F; Nucera E; Jaubashi K; Villalta D; Dagna L; Ciotta D; Pucciarini F; Bagnasco D; Celi G; Chieco Bianchi F; Cosmi L; Costantino MT; Crivellaro MA; D'Alò S; Del Biondo P; Del Giacco S; Di Gioacchino M; Di Pietro L; Favero E; Gangemi S; Guarnieri G; Heffler E; Leto Barone MS; Lombardo C; Losa F; Matucci A; Minciullo PL; Parronchi P; Passalacqua G; Pucci S; Rossi O; Salvati L; Schiappoli M; Senna G; Vianello A; Vultaggio A; Baoran Y; Incorvaia C; Canonica GW
    Clin Mol Allergy; 2022 May; 20(1):6. PubMed ID: 35590407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression.
    Pelaia C; Crimi C; Benfante A; Caiaffa MF; Calabrese C; Carpagnano GE; Ciotta D; D'Amato M; Macchia L; Nolasco S; Pelaia G; Pellegrino S; Scichilone N; Scioscia G; Spadaro G; Valenti G; Vatrella A; Crimi N
    J Asthma Allergy; 2021; 14():163-173. PubMed ID: 33654413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis.
    Busse WW; Maspero JF; Lu Y; Corren J; Hanania NA; Chipps BE; Katelaris CH; FitzGerald JM; Quirce S; Ford LB; Rice MS; Kamat S; Khan AH; Jagerschmidt A; Harel S; Rowe P; Pirozzi G; Amin N; Ruddy M; Graham NMH; Teper A
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):565-576.e1. PubMed ID: 32474156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updated Evaluation of Dupilumab in the Treatment of Asthma: Patient Selection and Reported Outcomes.
    Brooks GD
    Ther Clin Risk Manag; 2020; 16():181-187. PubMed ID: 32184610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13.
    Pelaia C; Pelaia G; Crimi C; Maglio A; Armentaro G; Calabrese C; Sciacqua A; Gallelli L; Vatrella A
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma.
    Castro M; Rabe KF; Corren J; Pavord ID; Katelaris CH; Tohda Y; Zhang B; Rice MS; Maroni J; Rowe P; Pirozzi G; Amin N; Ruddy M; Akinlade B; Graham NMH; Teper A
    ERJ Open Res; 2020 Jan; 6(1):. PubMed ID: 32010719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma.
    Corren J; Castro M; O'Riordan T; Hanania NA; Pavord ID; Quirce S; Chipps BE; Wenzel SE; Thangavelu K; Rice MS; Harel S; Jagerschmidt A; Khan AH; Kamat S; Maroni J; Rowe P; Lu Y; Amin N; Pirozzi G; Ruddy M; Graham NMH; Teper A
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):516-526. PubMed ID: 31521831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dupilumab therapy for patients with refractory eosinophilic otitis media associated with bronchial asthma.
    Iino Y; Sekine Y; Yoshida S; Kikuchi S
    Auris Nasus Larynx; 2021 Jun; 48(3):353-360. PubMed ID: 32943257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.
    Wenzel S; Castro M; Corren J; Maspero J; Wang L; Zhang B; Pirozzi G; Sutherland ER; Evans RR; Joish VN; Eckert L; Graham NM; Stahl N; Yancopoulos GD; Louis-Tisserand M; Teper A
    Lancet; 2016 Jul; 388(10039):31-44. PubMed ID: 27130691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets.
    Pelaia C; Heffler E; Crimi C; Maglio A; Vatrella A; Pelaia G; Canonica GW
    Front Pharmacol; 2022; 13():851940. PubMed ID: 35350765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dupilumab: A New Paradigm for the Treatment of Allergic Diseases.
    Sastre J; Dávila I
    J Investig Allergol Clin Immunol; 2018 Jun; 28(3):139-150. PubMed ID: 29939132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis.
    Jonstam K; Swanson BN; Mannent LP; Cardell LO; Tian N; Wang Y; Zhang D; Fan C; Holtappels G; Hamilton JD; Grabher A; Graham NMH; Pirozzi G; Bachert C
    Allergy; 2019 Apr; 74(4):743-752. PubMed ID: 30488542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis.
    Bagnasco D; Brussino L; Bonavia M; Calzolari E; Caminati M; Caruso C; D'Amato M; De Ferrari L; Di Marco F; Imeri G; Di Bona D; Gilardenghi A; Guida G; Lombardi C; Milanese M; Nicolini A; Riccio AM; Rolla G; Santus P; Senna G; Passalacqua G
    Respir Med; 2020 Sep; 171():106080. PubMed ID: 32917354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study.
    Nolasco S; Crimi C; Pelaia C; Benfante A; Caiaffa MF; Calabrese C; Carpagnano GE; Ciotta D; D'Amato M; Macchia L; Pelaia G; Pellegrino S; Scichilone N; Scioscia G; Spadaro G; Campisi R; Valenti G; Vatrella A; Crimi N
    J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4371-4380.e4. PubMed ID: 34419679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab Improves Asthma Control and Lung Function in Patients with Insufficient Outcome During Previous Antibody Therapy.
    Mümmler C; Munker D; Barnikel M; Veit T; Kayser MZ; Welte T; Behr J; Kneidinger N; Suhling H; Milger K
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1177-1185.e4. PubMed ID: 32980583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.